logo-loader
viewWeedMD Inc

WeedMD expands its product portfolio with launch of new vapes

The product line, which is made in-house at WeedMD’s extraction hub CX Industries, will be available to medical patients in coming weeks

WeedMD Inc -
The product will initially launch with the Ghost Train Haze strain, followed by Mango Haze and soon after a high CBD-strain format

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) said it had expanded its medical cannabis product portfolio with the launch of its strain-specific ‘Aurum’ vapes.

The product line, which is made in-house at WeedMD’s extraction hub CX Industries, will be available to medical patients in coming weeks, the group said.

It will also be rolled out into the adult-use market under the Color Cannabis brand in the third quarter of this year, said WeedMD.

READ: WeedMD launches same-day medical cannabis home delivery service in greater Toronto-area

The product will initially launch with the Ghost Train Haze strain, followed by Mango Haze and soon after a high CBD-strain format.

"Our Cannabis 2.0 strategy evolved after thoughtful consideration of our medical clients’ need for relief from specific indications that may require precise cannabis dosing via alternate delivery methods,” Angelo Tsebelis, the chief executive of WeedMD, said in a statement.

"When paired with our in-house talent in cultivating, extracting, and processing, we developed Aurum as a perfect alternative consumption method. In keeping with our medical roots, we are proud to launch Aurum as a refined medical product that complements our quality-produced portfolio."

The Aurum vape hardware is powered by New York-based Blinc Group, designers of premium customized vaporizers, highlighted WeedMD.

"Aurum is the finished product of many months of testing, perfecting formulations and collaborating between our team and our partner, the Blinc Group, to ensure we deliver a safe and high-quality product to our patients," added Moe Jiwan, chief customer officer at the firm.

The ‘Aurum’ vapes are available to the group's subsidiary Starseed Medicinal Inc's patients across Canada as part of WeedMD's expanding medical cannabis product portfolio as an insured benefit.

WeedMD Inc is the parent company of WeedMD RX Inc and Starseed Medicinal Inc federally-licensed producers of cannabis products for both the medical and adult-use markets.

Contact the author at [email protected]

Quick facts: WeedMD Inc

Price: 0.38 CAD

TSX-V:WMD
Market: TSX-V
Market Cap: $79.9 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 2/12/19

2 min read